These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 35124908)
1. Diagnostic Utility Of Fish For MDM2 In Adipocytic Neoplasms. Sarwar S; Mushtaq S; Hassan U; Maqbool H; Qazi R J Ayub Med Coll Abbottabad; 2021; 33(4):563-567. PubMed ID: 35124908 [TBL] [Abstract][Full Text] [Related]
2. Atypical lipomatous tumor/well differentiated liposarcoma and related mimics with updates. When is molecular testing most cost-effective, necessary, and indicated? Kilpatrick SE Hum Pathol; 2024 May; 147():82-91. PubMed ID: 38135062 [TBL] [Abstract][Full Text] [Related]
3. Lessons learnt from MDM2 fluorescence in-situ hybridisation analysis of 439 mature lipomatous lesions with an emphasis on atypical lipomatous tumour/well-differentiated liposarcoma lacking cytological atypia. Vargas AC; Joy C; Cheah AL; Jones M; Bonar F; Brookwell R; Garrone B; Talbot J; Harraway J; Gill AJ; Maclean FM Histopathology; 2022 Jan; 80(2):369-380. PubMed ID: 34523152 [TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Weaver J; Downs-Kelly E; Goldblum JR; Turner S; Kulkarni S; Tubbs RR; Rubin BP; Skacel M Mod Pathol; 2008 Aug; 21(8):943-9. PubMed ID: 18500263 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor. Kashima T; Halai D; Ye H; Hing SN; Delaney D; Pollock R; O'Donnell P; Tirabosco R; Flanagan AM Mod Pathol; 2012 Oct; 25(10):1384-96. PubMed ID: 22699518 [TBL] [Abstract][Full Text] [Related]
6. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics. Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411 [TBL] [Abstract][Full Text] [Related]
7. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748 [TBL] [Abstract][Full Text] [Related]
8. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers. Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516 [TBL] [Abstract][Full Text] [Related]
9. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Features Mimicking Spindle Cell Lipoma. Jebastin JAS; Perry KD; Chitale DA; Mott MP; Sanchez J; Fritchie KJ; Palanisamy N; Williamson SR Int J Surg Pathol; 2020 May; 28(3):336-340. PubMed ID: 31672072 [TBL] [Abstract][Full Text] [Related]
10. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH). Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065 [TBL] [Abstract][Full Text] [Related]
11. [Clinical value of fluorescence Wang W; Li X; Liu P; Dong Y Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors. Thway K; Flora R; Shah C; Olmos D; Fisher C Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498 [TBL] [Abstract][Full Text] [Related]
13. MDM2 RNA In Situ Hybridization for the Diagnosis of Atypical Lipomatous Tumor: A Study Evaluating DNA, RNA, and Protein Expression. Kulkarni AS; Wojcik JB; Chougule A; Arora K; Chittampalli Y; Kurzawa P; Mullen JT; Chebib I; Nielsen GP; Rivera MN; Ting DT; Deshpande V Am J Surg Pathol; 2019 Apr; 43(4):446-454. PubMed ID: 30520819 [TBL] [Abstract][Full Text] [Related]
14. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall. Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315 [TBL] [Abstract][Full Text] [Related]
15. MDM2 Amplification in Problematic Lipomatous Tumors: Analysis of FISH Testing Criteria. Clay MR; Martinez AP; Weiss SW; Edgar MA Am J Surg Pathol; 2015 Oct; 39(10):1433-9. PubMed ID: 26146760 [TBL] [Abstract][Full Text] [Related]
16. Amplification of FRS2 in atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases. Jing W; Lan T; Chen H; Zhang Z; Chen M; Peng R; He X; Zhang H Histopathology; 2018 Jun; 72(7):1145-1155. PubMed ID: 29368794 [TBL] [Abstract][Full Text] [Related]
17. Detection of Rekhi B; Karnik N; Agrawal R; Shetty O; Patkar S Indian J Pathol Microbiol; 2022; 65(1):65-75. PubMed ID: 35074968 [TBL] [Abstract][Full Text] [Related]
18. Histopathological Correlation of Chromosome 12 Polysomy by Fluorescence in Situ Hybridization in Adipocytic Neoplasms. Wilcock DM; McMurtry V; Coleman JF; Kim JT; Khalili P; Deftereos G; Albertson D; Gulbahce EH; Liu T; Sirohi D Int J Surg Pathol; 2022 Oct; 30(7):734-742. PubMed ID: 35261272 [No Abstract] [Full Text] [Related]
19. Differential diagnosis of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma by cytological analysis. Sugiyama K; Washimi K; Sato S; Hiruma T; Sakai M; Okubo Y; Miyagi Y; Yokose T Diagn Cytopathol; 2022 Mar; 50(3):112-122. PubMed ID: 34984861 [TBL] [Abstract][Full Text] [Related]
20. Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors. Zhang H; Erickson-Johnson M; Wang X; Oliveira JL; Nascimento AG; Sim FH; Wenger DE; Zamolyi RQ; Pannain VL; Oliveira AM Am J Surg Pathol; 2010 Sep; 34(9):1304-11. PubMed ID: 20679883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]